Nigeria Lags in Research and Development on Mpox, Says Academy of Medicine

Academy of Medicine Specialties on Public Health has raised concerns over the lack of research and development efforts on Mpox (formerly known as Monkeypox) in Nigeria. Despite the rising global attention on infectious diseases, the Academy pointed out that the country has made little to no progress in studying and combating Mpox.

Mpox, which has seen outbreaks in various parts of the world, requires urgent attention in terms of research, vaccine development, and public health interventions. Nigeria, as one of the countries affected by the disease, is in need of robust efforts to address the gaps in understanding and controlling its spread.

The Academy urged the Nigerian government, healthcare professionals, and research institutions to prioritize research on Mpox to ensure that the nation is better equipped to handle future outbreaks. The call also emphasized the importance of international collaboration in advancing medical research and strengthening public health policies in Nigeria.

Why This Matters

With the global rise of infectious diseases, addressing research gaps in diseases like Mpox is crucial. Without adequate research and development, the country may face challenges in managing outbreaks, protecting public health, and ensuring that future generations are prepared.